BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22532702)

  • 1. Intermediate phenotype analysis of patients, unaffected siblings, and healthy controls identifies VMAT2 as a candidate gene for psychotic disorder and neurocognition.
    Simons CJ; van Winkel R;
    Schizophr Bull; 2013 Jul; 39(4):848-56. PubMed ID: 22532702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic gene polymorphisms and cognitive function in a north Indian schizophrenia cohort.
    Kukshal P; Kodavali VC; Srivastava V; Wood J; McClain L; Bhatia T; Bhagwat AM; Deshpande SN; Nimgaonkar VL; Thelma BK
    J Psychiatr Res; 2013 Nov; 47(11):1615-22. PubMed ID: 23932573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia.
    Zai CC; Tiwari AK; Mazzoco M; de Luca V; Müller DJ; Shaikh SA; Lohoff FW; Freeman N; Voineskos AN; Potkin SG; Lieberman JA; Meltzer HY; Remington G; Kennedy JL
    J Psychiatr Res; 2013 Nov; 47(11):1760-5. PubMed ID: 24018103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.
    Meijer JH; Dekker N; Koeter MW; Quee PJ; van Beveren NJ; Meijer CJ;
    Psychol Med; 2012 Apr; 42(4):705-16. PubMed ID: 21899795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replicated evidence that endophenotypic expression of schizophrenia polygenic risk is greater in healthy siblings of patients compared to controls, suggesting gene-environment interaction. The EUGEI study.
    van Os J; Pries LK; Delespaul P; Kenis G; Luykx JJ; Lin BD; Richards AL; Akdede B; Binbay T; Altınyazar V; Yalınçetin B; Gümüş-Akay G; Cihan B; Soygür H; Ulaş H; Cankurtaran EŞ; Kaymak SU; Mihaljevic MM; Petrovic SA; Mirjanic T; Bernardo M; Cabrera B; Bobes J; Saiz PA; García-Portilla MP; Sanjuan J; Aguilar EJ; Santos JL; Jiménez-López E; Arrojo M; Carracedo A; López G; González-Peñas J; Parellada M; Maric NP; Atbaşoğlu C; Ucok A; Alptekin K; Saka MC; ; Arango C; O'Donovan M; Rutten BPF; Guloksuz S
    Psychol Med; 2020 Aug; 50(11):1884-1897. PubMed ID: 31414981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
    Jabben N; Arts B; van Os J; Krabbendam L
    J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of anhedonia and cognition in persons with schizophrenia spectrum disorders, their siblings, and controls.
    Kuha A; Suvisaari J; Perälä J; Eerola M; Saarni SS; Partonen T; Lönnqvist J; Tuulio-Henriksson A
    J Nerv Ment Dis; 2011 Jan; 199(1):30-7. PubMed ID: 21206244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder.
    van Winkel R; van Beveren NJ; Simons C;
    Neuropsychopharmacology; 2011 Nov; 36(12):2529-37. PubMed ID: 21775978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic association analysis of 300 genes identifies a risk haplotype in SLC18A2 for post-traumatic stress disorder in two independent samples.
    Solovieff N; Roberts AL; Ratanatharathorn A; Haloosim M; De Vivo I; King AP; Liberzon I; Aiello A; Uddin M; Wildman DE; Galea S; Smoller JW; Purcell SM; Koenen KC
    Neuropsychopharmacology; 2014 Jul; 39(8):1872-9. PubMed ID: 24525708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association study of dopamine receptor genes polymorphism with cognitive functions in bipolar I disorder patients.
    Zhao L; Lin Y; Lao G; Wang Y; Guan L; Wei J; Yang Z; Ni P; Li X; Jiang Z; Li T; Hao X; Lin D; Cao L; Ma X
    J Affect Disord; 2015 Jan; 170():85-90. PubMed ID: 25233244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in psychosis gene ZNF804A is associated with a refined schizotypy phenotype but not neurocognitive performance in a large young male population.
    Stefanis NC; Hatzimanolis A; Avramopoulos D; Smyrnis N; Evdokimidis I; Stefanis CN; Weinberger DR; Straub RE
    Schizophr Bull; 2013 Nov; 39(6):1252-60. PubMed ID: 23155182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel gene-brain structure relationships in psychotic disorder revealed using parallel independent component analyses.
    Tandon N; Nanda P; Padmanabhan JL; Mathew IT; Eack SM; Narayanan B; Meda SA; Bergen SE; Ruaño G; Windemuth A; Kocherla M; Petryshen TL; Clementz B; Sweeney J; Tamminga C; Pearlson G; Keshavan MS
    Schizophr Res; 2017 Apr; 182():74-83. PubMed ID: 27789186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging role of the FKBP5 gene polymorphisms in vulnerability-stress model of schizophrenia: further evidence from a Serbian population.
    Mihaljevic M; Zeljic K; Soldatovic I; Andric S; Mirjanic T; Richards A; Mantripragada K; Pekmezovic T; Novakovic I; Maric NP
    Eur Arch Psychiatry Clin Neurosci; 2017 Sep; 267(6):527-539. PubMed ID: 27552816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FKBP5 as a possible moderator of the psychosis-inducing effects of childhood trauma.
    Collip D; Myin-Germeys I; Wichers M; Jacobs N; Derom C; Thiery E; Lataster T; Simons C; Delespaul P; Marcelis M; van Os J; van Winkel R
    Br J Psychiatry; 2013 Apr; 202(4):261-8. PubMed ID: 23429203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis.
    Rosa A; Peralta V; Cuesta MJ; Zarzuela A; Serrano F; Martínez-Larrea A; Fañanás L
    Am J Psychiatry; 2004 Jun; 161(6):1110-2. PubMed ID: 15169701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Variation in the Vesicular Monoamine Transporter: Preliminary Associations With Cognitive Outcomes After Severe Traumatic Brain Injury.
    Markos SM; Failla MD; Ritter AC; Dixon CE; Conley YP; Ricker JH; Arenth PM; Juengst SB; Wagner AK
    J Head Trauma Rehabil; 2017; 32(2):E24-E34. PubMed ID: 26828714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Dopamine Receptor D2 (DRD2) Variations rs6277 and rs1800497 and Cognitive Performance According to Risk Type for Psychosis: A Nested Case Control Study in a Finnish Population Sample.
    Ramsay H; Barnett JH; Miettunen J; Mukkala S; Mäki P; Liuhanen J; Murray GK; Jarvelin MR; Ollila H; Paunio T; Veijola J
    PLoS One; 2015; 10(6):e0127602. PubMed ID: 26114663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association analysis of polymorphisms in VMAT2 and TMEM106B genes for Parkinson's disease, amyotrophic lateral sclerosis and multiple system atrophy.
    Hu T; Chen Y; Ou R; Wei Q; Cao B; Zhao B; Wu Y; Song W; Chen X; Shang HF
    J Neurol Sci; 2017 Jun; 377():65-71. PubMed ID: 28477711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are genetic risk factors for psychosis also associated with dimension-specific psychotic experiences in adolescence?
    Sieradzka D; Power RA; Freeman D; Cardno AG; McGuire P; Plomin R; Meaburn EL; Dudbridge F; Ronald A
    PLoS One; 2014; 9(4):e94398. PubMed ID: 24718684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCF4 sequence variants and mRNA levels are associated with neurodevelopmental characteristics in psychotic disorders.
    Wirgenes KV; Sønderby IE; Haukvik UK; Mattingsdal M; Tesli M; Athanasiu L; Sundet K; Røssberg JI; Dale AM; Brown AA; Agartz I; Melle I; Djurovic S; Andreassen OA
    Transl Psychiatry; 2012 May; 2(5):e112. PubMed ID: 22832956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.